Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 47 for “"KMT2D"”.
-
Comprehensive and integrative analysis of the KMT2D regulome
Lysine (K)-specific methyltransferase 2D (KMT2D) is a critical component of epigenetic regulation through its role in mono-methylation of lysine 4 of histone H3 (H3K4me1). KMT2D is among the most frequently mutated genes in many forms of cancer, with particularly high occurrence of mutation in …
-
Elucidating the Role of KMT2D in HER2+ Breast Cancer
… expression of the critical epigenetic regulator, KMT2D. Our preliminary data showed that BT474 HER2+ cells that had acquired resistance to trastuzumab expressed higher levels of KMT2D than those of the isogenic, parental trastuzumab-sensitive cells. KMT2D was also shown to be necessary for …
-
Genetic analysis of Kmt2d loss in tumorigenesis using genetically engineered mouse models
… regulators in COMPASS and SWI/SNF complexes. KMT2D, a histone H3K4 methyltransferase in the COMPASS complex, is frequently mutated in human lymphoma, melanoma, and epithelial carcinoma. Biochemically, KMT2D shapes the cellular enhancer landscape as the major writer of the putative enhancer …
-
Fbxw7 Triggers Degradation Of Kmt2d To Favor Growth Of Mature B-Type Malignant Cells
… is an E3 ligase for the lysine methyltransferase KMT2D. We show that FBXW7 utilizes its conserved WD40 domain to interact with KMT2D. KMT2D contains a stretch of N-terminal phosphodegron repeats that mediate interaction with FBXW7. These phosphodegrons are phosphorylated in cells and …
-
THE DEVELOPMENTAL LOGIC OF ENHANCEROPATHIES CAUSED BY KMT2D AND YY1 HAPLOINSUFFICIENCY THROUGH PATIENT-DERIVED DISEASE MODELING PLATFORMS
… caused by germline mutations in the enzyme KMT2D, which is involved in enhancer activation, and of Gabriele-de Vries syndrome, caused by mutations in YY1, which mediates DNA looping between gene promoters and enhancers. These two diseases thus belong to the class of enhanceropathies. Using …
-
Generation and characterization of a lysine (K)-specific methyltransferase 2D knockout human cell line
Lysine (K)-specific methyltransferase 2D (KMT2D) encodes a histone-lysine N-methyltransferase that catalyzes the methylation of histone 3 lysine 4 (H3K4me), which is an epigenetic modification involved in transcriptional regulation. KMT2D is a recurrent target of somatic mutation in at least 27 …
-
Funktionelle Untersuchung von genetischen Faktoren mit prognostischer Relevanz in der Onkologie
… Modifikatoren wie die H3K4-Methyltransferase KMT2D und das Chromatin-Bindeprotein (Reader) BRD4 sind häufig in verschiedenen Krebsarten wie z.B. in NSCLC mutiert. Im Rahmen dieser Doktorarbeit sollten in verschiedenen Lungenkrebszelllinien unter Verwendung von CRISPR CAS9 definierte Mutationen …
-
Kabuki syndrome: Reversing Intellectual Disability by Promoting Open Chromatin
… syndrome caused by mutations in two genes (KMT2D and KDM6A) both involved in promoting open chromatin. If an imbalance between open and closed chromatin states is central to the pathogenesis of KS, we hypothesized that agents that promote chromatin opening might have therapeutic potential. …
-
New insights into the basis of neurogenesis defects in Kabuki syndrome
… enzymes, lysine-specific methyltransferase 2D (KMT2D) and lysine-specific demethylase 6A (KDM6A/UTX) cause the congenital, multisystem intellectual disability (ID) disorder Kabuki syndrome (KS1 and KS2, respectively). A mouse model of KS1, Kmt2d(+/βgeo), demonstrated visuospatial memory …
-
Li-Fraumeni Syndrome tp53 Hotspot Mutant Zebrafish Exhibit Variant-Specific p53 Dysfunction and Tumour Development Which is Accelerated by kmt2d and pik3ca Modifier Mutations
… as acquired mutations in modifier genes, such as KMT2D and PIK3CA. Zebrafish are a powerful cancer modelling tool due to their high degree of genetic conservation and tumour development that resembles those found in humans. I characterized two tp53 mutant zebrafish, R217H and R242H, (human hotspot …
-
Molecular Biomarkers in Glioblastoma
… and identified novel candidate biomarkers (KMT2D, CPAMD8, MUC16, DYNC1I1) which may contribute to more accurate patient prognostication (Chapter 4). Chapter 5: biomarkers were further analysed in a larger patient cohort to confirm the initial findings. One of our novel candidate biomarkers …
-
An Investigation of Epigenetic Mechanisms Driving The Biology of Head and Neck Squamous Cell Carcinoma
… In the third project, I investigate the role of KMT2D, a histone methyltransferase that is the most highly mutated epigenetic gene in HNSCC, in regulating tumorigenesis and the tumor microenvironment. KMT2D is demonstrated to function as a tumor suppressor, the loss of which is associated with …
-
MECHANISMS OF EPIGENETIC REGULATION IN HORMONE-DRIVEN CANCERS AND DEVELOPMENT
… 3 focuses on the lysine methyltransferase KMT2D in castration-resistant prostate cancer (CRPC). While many CRPC tumors remain androgen receptor (AR)-dependent, recent studies identify a stem cell-like (SCL) subtype with reduced AR signaling and aggressive behavior. We show that KMT2D …
-
Mapping in silico genetic networks of tumour suppressor genes to uncover novel gene functions and predict cancer cell vulnerabilities
… networks of two tumour suppressor genes, CIC and KMT2D. To characterise CIC’s biological functions, I collaborated to perform multi-omic analyses and revealed new interactions with SWItch/Sucrose Non-Fermentable (SWI/SNF) complex members and a novel potential role in maintaining mitotic integrity. …
-
METASTASIS IN MALIGNANT PHYLLODES TUMOURS OF THE BREAST - DEFINING PROGNOSTIC FACTORS
… metastases revealed TERT promoter, MED12, TP53, KMT2D, FLNA and SETD2 to be the 6 most frequently mutated genes. Application of this gene panel also helped refine PT diagnosis. High protein expression of TERT, KMT2D, FLNA and SETD2 correlated with unfavourable histological parameters and/or …
-
Causes and consequences of disrupted chromatin opening: Kabuki syndrome and related disorders
… of two genes encoding histone modifying enzymes (KMT2D and KDM6A), resulting in an inability to open chromatin. To clarify mechanisms driving KS-associated immune deficiency, we evaluated humoral immunity in an established KS (Kmt2d+/βGeo) mouse model. We found that Kmt2d haploinsufficiency has …
-
Identification of critical hypoxia-induced factors in prostate cancer treatment resistance
… and histone methyltransferases, including KMT2C, KMT2D and SMARCA4, were significantly depleted (FDR < 0.05), indicating enhancer-mediated transcriptional dependencies. Functional validation demonstrated that silencing KMT2C and KMT2D reduced survival by 40% under hypoxia but not normoxia. RNA-seq …
-
Congenital Heart Disease Gene Identification by Whole Exome Sequencing
… choanal atresia and CHD a candidate variant in KMT2D was identified. The phenotype was distinct from Kabuki syndrome and is likely to represent a novel KMT2D-related disorder. WES was a successful tool in gene identification in CHD and, coupled with functional studies, has provided novel …
-
Hochdurchsatz-Sequenz-Analyse zur Identifikation von prädisponierenden sowie somatischen Mutationen bei Patienten mit Nicht-kleinzelligem Bronchialkarzinom (NSCLC) zur Vorhersage von Chemotherapie-Resistenzen
… Hinweise darauf, dass MAML2, CDC42BPA und KMT2D einen Einfluss auf die Sensitivität gegenüber dem EGFR Inhibitor Cetuximab haben könnten. Abschließend erfolgte eine erste Integration unterschiedlicher Datensätze, um Auswirkungen der identifizierten KMT2D Mutationen zu ermitteln. …
-
Role of chromatin condensates in tuning nuclear mechano-sensing in Kabuki Syndrome
… disease caused by the haploinsufficiency in the KMT2D gene encoding for MLL4, a H3K4-specific methyltransferase important for the regulation of gene expression. By interrogating the effect of KMT2D haploinsufficiency in Mesenchymal Stem Cells (MSCs) we discovered that MLL4 loss of function (LoF) …
Page 1 of 3